A new crystal form of nateglinide

Yaoxue Xuebao

Volumn 36, Issue 7, 2001, Pages 532-534

  Li, Gang ^a   Su, Guo Qiang ^b   Xu, Qun Wei ^b   Zhu, Chong Quan ^b  

^a NANJING NORMAL UNIVERSITY   (China)

^b Jiangsu Institute of Materia Medica   (China)

Author keywords

Diabetes; Differential scan calorimetry; Infrared spectra; Nateglinide; X ray powder diffraction

Indexed keywords

ANTIDIABETIC AGENT; CYCLOHEXANE DERIVATIVE; DRUG DERIVATIVE; NATEGLINIDE; PHENYLALANINE;

ARTICLE; CHEMISTRY; CRYSTALLIZATION; INFRARED SPECTROSCOPY; POWDER DIFFRACTION; X RAY CRYSTALLOGRAPHY;

CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; CYCLOHEXANES; HYPOGLYCEMIC AGENTS; PHENYLALANINE; POWDER DIFFRACTION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SUPPORT, NON-U.S. GOV'T;

EID: 0042027460     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Leung SS, Padden BE, Munson EJ, et al. Hydration and dehydration behavior of aspartame hemihydrate [J]. J Pharm Sci, 1998,87(4):508-513.
2. Singh D, Marshall PV, Shields L, et al. Solid-state characterization of chlordiazepoxide polymorphs [J]. J Pharm Sci, 1998,87(5):655-662.
3. Wang J, Zhang RH, Sun SY. Studies on the polymorphism of nimodipine [J]. Acta Pharm Sin (in Chinese), 1995,30 (6):443-448.
4. Sumikawa M, Konguchi Y, Ohgane T, et al. Crystals of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine and methods for preparing them [P]. US Pat: 5488150, 1996-01-30.